AzTrials
AzTrials

Contraceptive UsageTECCNCT06682065

Telemedicine Contraceptive Counselling (TECC) Versus Standard Care

A study testing Telemedicine for contraceptive counseling (TECC) in people with Contraceptive Usage and Telemedicine, run by Karolinska Institutet at 2 sites in South Africa.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Overall purpose of the PILOT and RCT: This research project aims to increase access and uptake of contraception after abortion through the systematic development and testing of a new telemedicine service for contraceptive counselling (TECC). Read more about this study

Who is it for?
Ages 18 years and older, women onlyHealthy volunteers can take part
Conditions the study is for
Contraceptive Usage, Telemedicine
What is being tested?
Telemedicine for contraceptive counseling (TECC)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
510 participants
Where
2 sitesSouth Africa
Study dates
5 May 2024to 15 Feb 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult
  • Seeking either surgical or medical abortion
  • ≥ 18 years of age
  • Able to communicate and understand spoken and written English
  • With private access to a smart phone
  • Willing to participate in the study procedures

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Margit Endler contact

0789106286

margit.endler@ki.se

South Africa2 sites, 2 recruiting
  • Michael Mapongwana

    Cape Town

    Khanyisa Jacobs, RNM

    Recruiting
  • Mitchell´s Plain CHC

    Cape Town

    Margit Endler, 0789106286, margit.endler@ki.se

    Recruiting

Other trials in South Africa

About this study

Official title: Telemedicine Contraceptive Counselling (TECC) Versus Standard Care - a Pilot and Randomized Controlled Trial of Periabortion Contraceptive Counseling

Overall purpose of the PILOT and RCT:

This research project aims to increase access and uptake of contraception after abortion through the systematic development and testing of a new telemedicine service for contraceptive counselling (TECC). The investigators will perform a pilot study in South Africa, and multicenter randomized controlled trial in South Africa and Kenya with the following specific aims:

Read the detailed description

Overall purpose of the PILOT and RCT:

This research project aims to increase access and uptake of contraception after abortion through the systematic development and testing of a new telemedicine service for contraceptive counselling (TECC). The investigators will perform a pilot study in South Africa, and multicenter randomized controlled trial in South Africa and Kenya with the following specific aims:

  1. To design and test a user-friendly online service for contraceptive counseling informed by systematic research into the preference and experience of women in our study setting.
  2. To compare uptake of long-acting reversible contraception (LARC) after TECC and in-person contraceptive counseling.
  3. To compare rates of choice, uptake, and continuation of LARC or any contraceptive, satisfaction, preference for counseling, recurrent unintended pregnancy, and recurrent abortion after TECC and in-person contraceptive counseling.

PILOT STUDY Objective: To assess the acceptability of a new online e-health service for contraceptive counselling i.e., telemedicine contraceptive counseling (TECC)

Design: A mixed methods pilot study developing and testing a new TECC service preceding a randomized controlled trial Setting and duration: The study will take place at Mitchell's Plain's community health center (CHC) in Western Cape, between February November 2023 and December 2023.

Study population: 30 women seeking abortion either medical or surgical, ≥ 18 years of age, able to communicate and understand spoken and written English, with private access to a smartphone, and willing to participate in the study

Recruitment and consent: Recruitment, informed consent, baseline interview and randomization will take place at the clinics by one of two experienced field workers, fluent in English and isiXhosa/Afrikaans.

Intervention: Participants will test the TECC service while waiting at the clinic to see the nurse for their abortion consultation. A follow-up survey will be sent out and completed by phone if necessary at 2 weeks after enrolment in the study. Out of these 30 women, approximately 10 (or until data saturation is achieved) will participate in semi-structured in-depth interviews regarding their experience of using the TECC service.

Primary outcome collected at 2 weeks Main outcome variable will be a compound variable reflecting the proportion of women who choose a method after completing the TECC intervention and report 1) being satisfied or very satisfied with the service (affective attitude), 2) understanding the content and purpose of the intervention (coherence), 3) feeling confident in their ability to use the service (self-efficacy), 4) experiencing the service as easy to use (burden), 5) assessing service as likely to be of use in the community (effectiveness)

Secondary outcomes collected at 2 weeks

  1. Contraceptive method chosen by type (%)
  2. Choice of LARC (%), defined as choice of an IUD or a subdermal implant for contraception
  3. Change of method with respect to previous use (%)

Qualitative component Data collection - qualitative component Data will be collected through semi structured in depth interviews (IDIs), held in person or by phone after the second quantitative data collection point. The sample size is estimated to be until data saturation or up to 10 interviews. The interview guide for the IDIs will be developed to capture measures of the acceptability of the TECC service according to Sekhon et al.'s framework, i.e. how participants feel about the intervention (affective attitude), how much effort is required to participate in the intervention (burden), how well the intervention fits with the participants value system (ethicality), how well the intervention is understood (coherence), what benefits must be given up to utilize the intervention (opportunity costs), how likely the intervention is to work (perceived effectiveness), and the participants confidence in being able to use the intervention (self-efficacy). Emphasis will be on enhancing the quantitative findings and gaining a more comprehensive understanding of the acceptability of the TECC intervention. Especially aspects of the framework that are more difficult to explore quantitatively, such as ethicality and opportunity costs will be explored. Questions will be open ended, allowing new themes to emerge from the data, and the interview guide may be adapted to accommodate and explore themes emerging in the interviews.

RANDOMIZED CONTROLLED TRIAL

Objective:

Setting:

Population: 510 women seeking abortion either medical or surgical, < 13+0 weeks gestation, ≥18 years of age, able to communicate and understand spoken and written English, with private access to a smart phone, and willing to participate in the study.

Recruitment and consent: Recruitment, informed consent, baseline interview and randomization will take place at the clinics by one of two experienced field workers, fluent in English and isiXhosa/Afrikaans.

RCT: Participants will be randomly assigned to either standard care or TECC.

  1. Standard care: Contraceptive counselling with clinic nurse.
  2. TECC: While waiting for their abortion consultation with the clinic nurse, participants will use their phones to complete a contraceptive counseling session through the TECC service.

Outcome measures: The investigators will compare effectiveness and acceptability of the service between the telemedicine and the standard care arm. Follow-up will through links ot online surveys in RedCap at 12 weeks, 6 months and 12 months after the initial consultation.

Primary outcome at 12 weeks Uptake of LARC, defined as uptake of an IUD or a subdermal implant for contraception, within 12 weeks Secondary outcomes at 12 weeks

  1. choice of LARC
  2. uptake of any contraception
  3. choice or uptake of new method with regards to previous use
  4. satisfaction with TECC service (using a a multi-question validated scale)
  5. Rated use of service for decision making (using a multi-question validated scale)
  6. Degree of agency in decision making (using a a multi-question validated scale)
  7. preference for counselling Secondary outcomes at 6 months
  8. continued use of LARC 2. continued use of any contraception 3. recurrent unintended pregnancy 4. recurrent abortion Secondary outcomes at 12 months
  9. continued use of LARC
  10. continued use of any contraception
  11. recurrent unintended pregnancy
  12. recurrent abortion
  13. Change of method at any timepoint up to 12 months
  14. Reason for change of method
Being tested
Telemedicine for contraceptive counseling (TECC), Standard Care
Medical subject headings
Contraception Behavior

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Telemedicine for contraceptive counseling (TECC)Other

    WhatsApp algorithmic chatbot that screens preferences and medical eligibility to recommend two methods, informs about all methods, allows choice out of all methods, produce summary to substitute for clinical record

  • Standard CareOther

    In-personcontraceptive counseling with a nurese according to clinical standard of care

Study groups in NCT06682065
Study groupRoleWhat they receive
TelemedicineExperimentalWhatsApp algorithmic chatbot see further description
Receives: Other: Telemedicine for contraceptive counseling (TECC)
Standard CareActive comparatorStandard of care contraceptive counseling with clinic nurse
Receives: Other: Standard Care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Use of LARC (IUD or progestin implant) at 12 week follow-up

    Proportion of participants in each arm with using LARC (IUD or progestin implant) at 12 week follow-up

    Measured: 12 weeks

Secondary outcomes (12)
  1. Choice of LARC on day of consultation

    Proportion of participants in each arm chosing LARC on day of first visit (recruitment)

    Measured: Baseline

  2. Use of LARC at 6 months

    Proportion of participants in each arm using LARC at 6 months follow-up

    Measured: 6 months

  3. Use of LARC at 12 months

    Proportion of participants in each arm using LARC at 12 months follow-up

    Measured: 12 months

  4. Unplanned pregnancy within 6 months

    Proportion of participants in each arm with unplanned pregnancy recorded at 6 month follow-up and having occurred since previous abortion

    Measured: 6 months

  5. Unplanned pregnancy within 12 months

    Proportion of participants in each arm with unplanned pregnancy recorded at 12 month follow-up and having occurred since previous abortion.

    Measured: 12 months

  6. Recurrent abortion within 6 months

    Proportion of participants in each arm with recurrent abortion recorded at 6 month follow-up and having occurred since previous abortion

    Measured: 6 months

  7. Recurrent abortion within 12 months

    Proportion of participants in each arm with recurrent abortion recorded at 12 month follow-up and having occurred since previous abortion

    Measured: 12 months

  8. Preference for counseling model

    Proportion of participants in each arm using expressing preference for telemedicine counseling model

    Measured: Baseline

  9. Satisfaction with contraceptive counseling

    validated scale (0-6)

    Measured: Baseline

  10. Decision-competence after contraceptive counseling

    validated scale (0-100)

    Measured: Baseline

  11. Agency in contraceptive decision making

    modified validated scale

    Measured: Baseline

  12. Change of contraceptive method

    Change of contraceptive method

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Nov 2024
  2. Study start5 May 2024
  3. Primary completion15 Feb 2025 (estimated)
  4. Study completion15 Feb 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Model description
1:1
Masking
None (open label)
Enrolment
510 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06682065
Sponsor's protocol ID
TECC
Acronym
TECC
Status last verified
Nov 2024
First submitted
8 Apr 2024
Last updated
12 Nov 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Pseudonymized data will be made available to other researchers upon reasonable request

Questions about this trial

What is this clinical trial studying?

A study testing Telemedicine for contraceptive counseling (TECC) in people with Contraceptive Usage and Telemedicine, run by Karolinska Institutet at 2 sites in South Africa.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 12 Nov 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in South Africa. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Margit Endler (0789106286, margit.endler@ki.se), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Use of LARC (IUD or progestin implant) at 12 week follow-up (time frame: 12 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Nov 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in